New Results
Vectored Immunoprophylaxis and Treatment of SARS-CoV-2 Infection
View ORCID ProfileTakuya Tada, View ORCID ProfileBelinda M. Dcosta, Julia Minnee, View ORCID ProfileNathaniel R. Landau
doi: https://doi.org/10.1101/2023.01.11.523649
Takuya Tada
1Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA
Belinda M. Dcosta
1Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA
Julia Minnee
1Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA
Nathaniel R. Landau
1Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA
Article usage
Posted January 12, 2023.
Vectored Immunoprophylaxis and Treatment of SARS-CoV-2 Infection
Takuya Tada, Belinda M. Dcosta, Julia Minnee, Nathaniel R. Landau
bioRxiv 2023.01.11.523649; doi: https://doi.org/10.1101/2023.01.11.523649
Subject Area
Subject Areas
- Biochemistry (11744)
- Bioengineering (8751)
- Bioinformatics (29193)
- Biophysics (14968)
- Cancer Biology (12094)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18303)
- Genetics (12244)
- Genomics (16801)
- Immunology (11866)
- Microbiology (28082)
- Molecular Biology (11592)
- Neuroscience (60959)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)